-
August 9, 2021 Contract Research Organizations Partner to Accelerate European Psychedelic Clinical TrialsA partnership between Clerkenwell Health and Transpharmation provides drug developers a one-stop-shop for all stages...
-
August 9, 2021 Surveys Show: America’s Public Approval of Psychedelic Therapy Lags Behind CanadaWe compare two polls of roughly the same sample size in two neighboring countries, and...
-
August 9, 2021 NEW MindMed teaming up With Pfizer, J&J and Johns Hopkins on Digital Medicines? (MNMD, PFE, JNJ)As technological change revolutionizes medicine and healthcare, how do we ensure that no-one, particularly members...
-
August 6, 2021 Filament Health Patents Extraction Technique for Superior, Cheaper Natural PsilocybinThe Vancouver-based company says it has overcome the challenges of natural extraction with its new...
-
August 6, 2021 Psychedelic Business Spotlight: August 6, 2021Another clinic gets approval to conduct MDMA research, and new psychedelic research facilities open in...
-
August 5, 2021 Why Dimensions Health Centers Founders Embrace Plant Medicine Ceremonies Over Clinical TreatmentCEO Christopher Dawson and COO Andrew Galloway spent years working in clinical mental health treatment...
-
August 5, 2021 Why These Researchers Are Concerned About Psychedelic LegalizationTwo researchers argue we still can’t be sure what the effects of widespread public use...
-
August 5, 2021 Meet MindMed’s Interim CEO: Robert Barrow | My First Impressions & CommentsMindMed's Interim CEO, Robert Barrow, has not made as many public appearances as opposed to...
-
August 4, 2021 The Spotlight Roundup- This Psychedelic VR Startup Raises Over $11 MillionAugust 4, 2021- This week’s Psychedelic Business News top stories include: - Virtual reality startup,...
-
August 4, 2021 FDA Green Lights Ketamine for Treatment of ALS"This designation not only expedites our regulatory, clinical, and product development plans but also validates...
